Correlation Between Pharmaceuticals Portfolio and Vanguard Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Portfolio and Vanguard Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Portfolio and Vanguard Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Portfolio Pharmaceuticals and Vanguard Health Care, you can compare the effects of market volatilities on Pharmaceuticals Portfolio and Vanguard Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Portfolio with a short position of Vanguard Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Portfolio and Vanguard Health.

Diversification Opportunities for Pharmaceuticals Portfolio and Vanguard Health

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pharmaceuticals and Vanguard is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Portfolio Phar and Vanguard Health Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard Health Care and Pharmaceuticals Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Portfolio Pharmaceuticals are associated (or correlated) with Vanguard Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard Health Care has no effect on the direction of Pharmaceuticals Portfolio i.e., Pharmaceuticals Portfolio and Vanguard Health go up and down completely randomly.

Pair Corralation between Pharmaceuticals Portfolio and Vanguard Health

Assuming the 90 days horizon Pharmaceuticals Portfolio Pharmaceuticals is expected to generate 1.07 times more return on investment than Vanguard Health. However, Pharmaceuticals Portfolio is 1.07 times more volatile than Vanguard Health Care. It trades about 0.06 of its potential returns per unit of risk. Vanguard Health Care is currently generating about 0.03 per unit of risk. If you would invest  2,018  in Pharmaceuticals Portfolio Pharmaceuticals on January 17, 2024 and sell it today you would earn a total of  618.00  from holding Pharmaceuticals Portfolio Pharmaceuticals or generate 30.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pharmaceuticals Portfolio Phar  vs.  Vanguard Health Care

 Performance 
       Timeline  
Pharmaceuticals Portfolio 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Portfolio Pharmaceuticals are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Pharmaceuticals Portfolio may actually be approaching a critical reversion point that can send shares even higher in May 2024.
Vanguard Health Care 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vanguard Health Care has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Vanguard Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pharmaceuticals Portfolio and Vanguard Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmaceuticals Portfolio and Vanguard Health

The main advantage of trading using opposite Pharmaceuticals Portfolio and Vanguard Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Portfolio position performs unexpectedly, Vanguard Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard Health will offset losses from the drop in Vanguard Health's long position.
The idea behind Pharmaceuticals Portfolio Pharmaceuticals and Vanguard Health Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm